- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03095157
The Emerging Role of Resolvins in the Prevention of Chronic Pain After Thoracic Surgery
March 23, 2017 updated by: Mieke A. Soens, Brigham and Women's Hospital
The aim of the study is to investigate whether pre-operative dysregulated systemic lipid mediator pathways are associated with increased risk for the development of persistent post surgical pain.
In addition we will investigate whether treatment with an over the counter dietary supplement containing a fractionated marine lipid derivative from anchovy and sardine oil prevents the development of chronic pain after surgery.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- scheduled to undergo esophagectomy at BWH
- 18-80 years old
Exclusion Criteria:
- pre-existing chronic pain
- current opioid use
- current treatment with corticosteroids
- evidence of active infection
- chronic liver disease
- end-stage renal disease (CKD-5)
- chronic inflammatory disorders
- recent major surgery or illness within 30 days
- use of immunosuppressive medication
- history of organ transplant
- pregnancy or plans to become pregnant
- lactating
- allergies to fish or fish oil
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo
|
Patients will be randomized to receive perioperative treatment versus placebo
|
|
Experimental: Treatment
|
Patients will be randomized to receive perioperative treatment versus placebo
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Numeric Rating Scale (0=no pain; 10=worst imaginable pain) at 3 months after surgery
Time Frame: 3 months
|
Persistent pain after thoracic surgery
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Primary Completion (Anticipated)
July 1, 2019
Study Registration Dates
First Submitted
March 16, 2017
First Submitted That Met QC Criteria
March 23, 2017
First Posted (Actual)
March 29, 2017
Study Record Updates
Last Update Posted (Actual)
March 29, 2017
Last Update Submitted That Met QC Criteria
March 23, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017P000346
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patients Scheduled for Thoracic Surgery/Esophagectomy Will be Enrolled
-
Loma Linda UniversityCompletedComparison of Telemedicine Evaluation to Standard Evaluation Methods for Pre-Anesthesia ConsultationENT Patients Scheduled for SurgeryUnited States
-
Ain Shams UniversityBritish University In EgyptActive, not recruitingPatients Scheduled for Any Oral Surgical Flap Procedure That Require Suturing Will Be Included in This StudyEgypt
-
Fundación para la Investigación del Hospital Clínico...Completed
-
University Hospital, GhentTerminatedASA Class I/II Patients Scheduled for Surgery Under General AnesthesiaBelgium
-
Balikesir UniversityCompletedLaparoscopic Hysterectomy | ASA Class I/II Patients Scheduled for Surgery Under General AnesthesiaTurkey (Türkiye)
-
Tel-Aviv Sourasky Medical CenterCompletedConsecutive Subjects Who Are Suitable for a Coronary | Angioplasty of de Novo Lesion(s) in Native Coronary | Arteries Should be Screened for Eligibility. | A Total Number of 200 Patients Fulfilling the Selection | Criteria and Willing to Sign the Informed Consent Should | be Enrolled in the...Israel
-
Fundación para la Investigación del Hospital Clínico...CompletedPatients With ASA Status I-III Scheduled for Elective SurgerySpain
-
Yonsei UniversityUnknownPatients Scheduled for Brain SurgeryKorea, Republic of
-
Novartis PharmaceuticalsCompletedPrimary Osteoarthritis Patients Scheduled for Total Knee Replacement SurgeryUnited States
-
Baskent UniversityActive, not recruitingoPAP Should be > 25mmHg in Right Heart Catheterization at Rest | There Should be Patients Who Will Undergo Non-cardiac and Non-obstetric SurgeryTurkey